Pfizer/BioNTech’s Comirnaty Supply Agreements Unaffected Despite EU Green Light For Under-12s
Comirnaty To Be First EU Approved Vaccine For 5 to 11 Year-Olds.
Executive Summary
Pfizer and BioNTech’s Comirnaty supply under existing agreements will continue as planned despite anticipated expansion into a new child sub-population in Europe.
You may also be interested in...
Comirnaty mRNA Vaccine First To Get EU Clearance For Under-12s
The EMA is going all out to maximize coverage of the EU population with both vaccines and treatments for COVID-19.
Coronavirus Notebook: Pfizer/BioNTech On Plans For EU Vaccine Rollout, COVAX Strikes New Deals
The latest round-up from the Pink Sheet of developments relating to COVID-19.